Traditionally, glucagon like peptide 1 analogs have been administered via subcutaneous injections, which can pose adherence challenges among patients, limiting widespread acceptance and consistent usage
En la reunin anual de 2023 de la Asociacin Europea para el Estudio de la Diabetes se han presentado los datos provisionales de un ensayo fase 2 llamado MOMEMTUM ** con el pemvidutide , un agonista dual del GLP-1 y glucagn, con 320 participantes con sobrepeso u obesidad, sin diabetes mellitus y con al menos una comorbilidad relacionada con la obesidad
This episode is really about awareness
Finkelstein, professor, Duke-NUS Medical School, Singapore, in a commentary about the study
Here are some key dietary recommendations: Eat smaller, more frequent meals: Large meals can put pressure on the stomach and increase acid production, which can irritate the stomach lining
Going above that consistently can cause problems of its own, including copper depletion, which creates a different set of issues